Nuvation Bio Inc Warrants
NUVB.WS
NUVB.WS was delisted on the 10th of February, 2026.
21 hedge funds and large institutions have $9.85M invested in Nuvation Bio Inc Warrants in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
116% more capital invested
Capital invested by funds: $4.55M → $9.85M (+$5.3M)
5% less funds holding
Funds holding: 22 → 21 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$137K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$19K |
| 3 |
HPCM
Hunter Perkins Capital Management
Lombard,
Illinois
|
+$4.39K |
| 4 |
IP
Intellectus Partners
San Francisco,
California
|
+$1.29K |
| 5 |
GCM
Greenland Capital Management
New York
|
+$944 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCA
Octagon Capital Advisors
New York
|
-$385K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16.8K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$2.04K |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$2.02K |
NUVB.WS Hedge Fund Activity: Q4 2025 in Review
21 of the 8,281 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q4 2025, worth a combined $9.85M — up 116% from $4.55M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NUVB.WS and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 4 added.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $137K. The largest seller was Octagon Capital Advisors, exiting entirely with an estimated $385K sold.
- 21 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q4 2025, down from 22 in Q3 2025.
- Funds reported $9.85M of Nuvation Bio Inc Warrants stock for Q4 2025, up 116% quarter-over-quarter.
- 2 funds opened new Nuvation Bio Inc Warrants positions in Q4 2025 and 3 closed out, a net change of -1 holder.
- The largest Nuvation Bio Inc Warrants buyer in Q4 2025 was Nantahala Capital Management, an estimated $137K added.
- The largest Nuvation Bio Inc Warrants seller in Q4 2025 was Octagon Capital Advisors, an estimated $385K sold.
Based on aggregated 13F filings for Q4 2025.